PD-(L)1 Inhibitors as Monotherapy for the First-Line Treatment of Non-Small-Cell Lung Cancer Patients with High PD-L1 Expression: A Network Meta-Analysis

por Majem, Margarita, Cobo, Manuel, Isla, Dolores, Marquez-Medina, Diego, Rodriguez-Abreu, Delvys, Casal-Rubio, Joaquín, Moran-Bueno, Teresa, Bernabé-Caro, Reyes, Pérez-Parente, Diego, Ruiz-Gracia, Pedro, Arroyo, Marta Marina, Paz-Ares, Luis
Publicado 2021

PD-(L)1 Inhibitors in Combination with Chemotherapy as First-Line Treatment for Non-Small-Cell Lung Cancer: A Pairwise Meta-Analysis

por García-González, Jorge, Ruiz-Bañobre, Juan, Afonso-Afonso, Francisco J., Amenedo-Gancedo, Margarita, Areses-Manrique, María del Carmen, Campos-Balea, Begoña, Casal-Rubio, Joaquín, Fernández-Núñez, Natalia, Fírvida Pérez, José Luis, Lázaro-Quintela, Martín, Pérez Parente, Diego, Crama, Leonardo, Ruiz-Gracia, Pedro, Santomé-Couto, Lucía, León-Mateos, Luis
Publicado 2020

Fluorescence in situ hybridization analysis of the ALK gene in 2,045 non-small cell lung cancer patients from North-Western Spain (Galicia)

por Sánchez-Ares, María, Cameselle-Teijeiro, José M., Vázquez-Estévez, Sergio, Lázaro-Quintela, Martín, Vázquez-Boquete, Ángel, Afonso-Afonso, Francisco J., Casal-Rubio, Joaquín, González-Piñeiro, Ana L., Rico-Rodríguez, Yolanda, Fírvida-Pérez, José L., Ruíz-Bañobre, Juan, Couso, Elena, Santomé, Lucía, Pérez-Becerra, Raquel, García-Campelo, Rosario, Amenedo, Margarita, Azpitarte-Raposeiras, Cristina, Antúnez, José, Abdulkader, Ihab
Publicado 2016

Lung cancer symptoms at diagnosis: results of a nationwide registry study

por Ruano-Raviña, Alberto, Provencio, Mariano, Calvo de Juan, Virginia, Carcereny, Enric, Moran, Teresa, Rodriguez-Abreu, Delvys, López-Castro, Rafael, Cuadrado Albite, Eugenio, Guirado, María, Gómez González, Lucía, Massutí, Bartomeu, Ortega Granados, Ana Laura, Blasco, Ana, Cobo, Manuel, Garcia-Campelo, Rosario, Bosch, Joaquim, Trigo, José, Juan, Óscar, Aguado de la Rosa, Carlos, Dómine, Manuel, Sala, María, Oramas, Juana, Casal-Rubio, Joaquín, Cerezo, Sara
Publicado 2020

Clinical and molecular parameters associated to pneumonitis development in non-small-cell lung cancer patients receiving chemoimmunotherapy from NADIM trial

por Sierra-Rodero, Belén, Cruz-Bermúdez, Alberto, Nadal, Ernest, Garitaonaindía, Yago, Insa, Amelia, Mosquera, Joaquín, Casal-Rubio, Joaquín, Dómine, Manuel, Majem, Margarita, Rodriguez-Abreu, Delvys, Martinez-Marti, Alex, De Castro Carpeño, Javier, Cobo, Manuel, López Vivanco, Guillermo, Del Barco, Edel, Bernabé Caro, Reyes, Viñolas, Nuria, Barneto Aranda, Isidoro, Viteri, Santiago, Massuti, Bartomeu, Laza-Briviesca, Raquel, Casarrubios, Marta, García-Grande, Aránzazu, Romero, Atocha, Franco, Fernando, Provencio, Mariano
Publicado 2021

Overall Survival and Biomarker Analysis of Neoadjuvant Nivolumab Plus Chemotherapy in Operable Stage IIIA Non–Small-Cell Lung Cancer (NADIM phase II trial)

por Provencio, Mariano, Serna-Blasco, Roberto, Nadal, Ernest, Insa, Amelia, García-Campelo, M. Rosario, Casal Rubio, Joaquín, Dómine, Manuel, Majem, Margarita, Rodríguez-Abreu, Delvys, Martínez-Martí, Alex, De Castro Carpeño, Javier, Cobo, Manuel, López Vivanco, Guillermo, Del Barco, Edel, Bernabé Caro, Reyes, Viñolas, Nuria, Barneto Aranda, Isidoro, Viteri, Santiago, Pereira, Eva, Royuela, Ana, Calvo, Virginia, Martín-López, Javier, García-García, Francisco, Casarrubios, Marta, Franco, Fernando, Sánchez-Herrero, Estela, Massuti, Bartomeu, Cruz-Bermúdez, Alberto, Romero, Atocha
Publicado 2022